News

Filter

Current filters:

Rapamune

1 to 9 of 81 results

Pfizer says Rapamune failed endpoints in renal transplant study

Pfizer says Rapamune failed endpoints in renal transplant study

09-11-2013

US pharma behemoth Pfizer released disappointing top-line results from a Phase IIIb/IV study of its already-marketed…

ImmunologicalsPfizerPharmaceuticalRapamuneResearch

Pfizer legacy company agrees near half billion dollar settlement with DoJ

31-07-2013

Wyeth Pharmaceuticals, a US pharma rival acquired by US behemoth Pfizer (NYSE:PFE) in 2009, has agreed…

FinancialImmunologicalsLegalMarkets & MarketingNorth AmericaPfizerPharmaceuticalRapamuneWyeth

Pfizer prevails in Rapamune patent dispute with Watson

01-02-2013

Global pharma behemoth Pfizer (NYSE: PFE) says that the US District Court for the District of Delaware…

ActavisGenericsImmunologicalsLegalNorth AmericaPatentsPfizerPharmaceuticalRapamuneWatson Pharmaceuticals

US lawmakers launch inquiry into allegations Wyeth/Pfizer marketed Rapamune to African Americans for not-FDA-approved uses

14-06-2010

The US House Oversight and Government Reform Committee, under the chairmanship of Representative Edolphus…

North AmericaOncologyPfizerPharmaceuticalPoliticsRapamuneRegulationWyeth

Santen's first-half income plummets 46%

08-12-2008

Santen Pharmaceuticals, a Japanese drugmaker, reported a severe fall in profit for the six months ending…

Rapamunesirolimus

Japan stock market week to June 9, 2008

16-06-2008

Tokyo retreated in the week ended June 9 due to profit-taking on select stocks. The Nikkei 225 fell 1.8%,…

Daiichi SankyoGlaxoSmithKlineGSKHumulin 70-30Humulin NHumulin RInsulinNystatinOralRapamuneSankyosirolimus

1 to 9 of 81 results

Back to top